Category Archives: in the news

The confusing world of online health information

KEY TAKEAWAY: Right now, medical devices are less rigorously regulated than drugs: Only 1 percent of medical devices get FDA approval with high-quality clinical trials behind them. Even in these cases, devices typically reach the market based on data from a single small, short-term trial, Redberg wrote in a 2014 editorial in the New England Journal of Medicine, where she called for a sham control study of stents.  So what do you do if you’re a stent patient or candidate? Continue reading

We need prescription drugs to compensate for poor lifestyles

KEY TAKEAWAY: Nearly 40% of adults and 19% of youth are obese , the highest rate the country has ever seen in all adults, according to research released Friday by the National Center for Health Statistics.  This, of course, means that the public is going to be more dependent on prescription drugs to maintain their health at the same time they complain about big pharma. Continue reading

Lowering the fraud of online ads

KEY TAKEAWAY: Online ad fraud is shaking the online advertising industry at a time when advertisers are pouring a ton of money into the channel.  However, what’s been overlooked is that the creative for most online ads is horrible. If pharma marketers want to lower the risk of online ad fraud and improve metrics they have to do two things: ditch programmatic and improve online ad creative. Continue reading

Pharma finally admits “digital is important”

KEY TAKEAWAY: GSK and Novartis have gone to the outside to hire senior digital marketing people with CPG experience.  While these moves are long overdue is it enough or is pharma waiting at the airport for their ship to come in? Continue reading